1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Sakar Healthcare Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
36.63% Fall from 52W High
-6.7
TTM PE Ratio
Below industry Median
52.3
Price to Book Ratio
Below industry Median
2.5
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-3.8
Sakar Healthcare Ltd Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Sakar Healthcare Ltd Quarterly Revenue
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
42.78 Cr | 41.15 Cr | 43.06 Cr | 37.23 Cr | 34.08 Cr |
Sakar Healthcare Ltd Yearly Revenue
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
156.53 Cr | 138.03 Cr | 130.4 Cr | 95.91 Cr | 85 Cr |
Sakar Healthcare Ltd Quarterly Net Profit/Loss
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
4.8 Cr | 2.41 Cr | 3.12 Cr | 2.07 Cr | 3.64 Cr |
Sakar Healthcare Ltd Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
11.67 Cr | 12.76 Cr | 15.18 Cr | 10.68 Cr | 9.62 Cr |
Sakar Healthcare Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
309.60
10Day EMA
311.70
12Day EMA
311.80
20Day EMA
311.00
26Day EMA
310.70
50Day EMA
311.30
100Day EMA
316.40
200Day EMA
324.20
5Day SMA
311.20
10Day SMA
315.90
20Day SMA
309.80
30Day SMA
307.30
50Day SMA
309.60
100Day SMA
314.60
150Day SMA
319.10
200Day SMA
329.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 21900 Rs | 32016 Rs |
Week Rs | 21732 Rs | 31399 Rs |
Month Rs | 28327 Rs | 41005 Rs |
Resistance & Support
306.07
Pivot
Resistance
First Resistance
311.28
Second Resistance
319.02
Third Resistance
324.23
Support
First Support
298.33
Second support
293.12
Third Support
285.38
Relative Strength Index
45.11
Money Flow Index
30.56
MACD
1.08
MACD Signal
1.90
Average True Range
12.02
Average Directional Index
17.62
Rate of Change (21)
6.56
Rate of Change (125)
-3.11
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
632.88 | 86.2 | 186 | ||
752.41 | 911.05 | 1753.95 | ||
Jenburkt Pharmaceuticals Ltd. | - | - | - | |
Vikram Thermo (India) Ltd. | - | - | - | |
664.47 | 355.45 | 630 | ||
Shree Ganesh Remedies Ltd. | - | - | - |
Sakar Healthcare Ltd Company background
Founded in: 2004
Managing director: Sanjay S Shah.
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 202223, the Company started commercialization with Oncology product post receiving WHO GMP certification.
Sakar Healthcare Ltd FAQs
How has Sakar Healthcare Ltd [SAKAR] shares performed in the past ?
The past 1-year return of Sakar Healthcare Ltd [SAKAR] share was -15.49. The Sakar Healthcare Ltd [SAKAR] share hit a 1-year low of Rs. 279.85 and a 1-year high of Rs. 479.
What is the market cap of Sakar Healthcare Ltd [SAKAR] ?
The market cap of Sakar Healthcare Ltd is Rs. 660.22 Cr. as of 12/19/2024 12:00:00 AM.
What is the current P/E ratio of Sakar Healthcare Ltd [SAKAR] share price ?
The PE ratios of Sakar Healthcare Ltd is 53.25 as of 12/19/2024 12:00:00 AM.
What is the current PB ratio of Sakar Healthcare Ltd [SAKAR] share price ?
The PB ratios of Sakar Healthcare Ltd is 2.44 as of 12/19/2024 12:00:00 AM
How can I buy Sakar Healthcare Ltd shares?
You can easily buy Sakar Healthcare Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
